After 42 Days, Turing Pharmaceuticals Has Yet to Take Action on Outrageous Price Hike
While HRC has continued to take action 42 days since Turing Pharmaceuticals CEO Martin Shkreli promised to lower the price on Daraprim, providers report that the hiked up price remains the same.
HRC.org
You Might Like